Health Finance Institute
Andrea Feigl serves as an Adjunct Professor at Georgetown University Walsh School of Foreign Service since December 2022 and is the Chief Executive Officer and founder of the Health Finance Institute, established after incubation at Harvard Kennedy School. Under Andrea Feigl's leadership, the Institute raised over 5 million USD within its first five years and received the UN Interagency Task Force Award for Non-Communicable Diseases in 2023. Andrea Feigl has developed impact evaluation plans for over 40 countries and positioned the organization as a market leader in innovative finance methodologies in the non-communicable disease sector. Previous roles include Senior Health Economist at Microclinic International, Health Economist positions at institutions such as Harvard T.H. Chan School of Public Health and OECD, as well as expertise consulting for the World Health Organization. Andrea Feigl obtained a PhD in Global Health from Harvard T.H. Chan School of Public Health and held various leadership and teaching roles at Harvard University, alongside educational qualifications in Public Health and Biochemistry from Simon Fraser University.
This person is not in any teams
This person is not in any offices
Health Finance Institute
The Health Finance Institute (HFI) is a US-based non-profit organization that aims to design, catalyze, test, and scale novel financing instruments and pathways for noncommunicable diseases, or NCDs (diabetes, heart disease, cancer, chronic obstructive pulmonary disease, and mental health), with an ultimate goal of accelerating the expansion of fiscal space for NCDs globally. At the heart of HFI’s mission is that nobody chooses disease, as research shows that NCDs stem from a range of environmental and societal, social determinants, and biological factors, and HFI recognizes the severe economic burden that NCDs have on a global economy. Non-communicable diseases (NCDs) are the leading cause of death and disability, globally. Yet, there continues to be an under investment in action and health financing by the global community. HFI’s vision is simple: to implement robust, evidence-based innovative funding mechanisms to broker partnerships across public and private sectors and leverage unique expertise across health and finance to close the current gap in funding for NCDs. As the COVID-19 infection rate climbs globally, HFI is uniquely positioned to call attention to a deeper understanding of the populations that are most at risk for severe infection and mortality due to COVID-19. HFI’s rapid response to the COVID-19 epidemic presents an opportunity not to alleviate the current burden facing health and financial systems, but also to build awareness of the potential impact of NCDs on future infectious disease outbreaks. The expert HFI team brings together decades of experience in health economics, tracking development assistance for health and non-communicable disease, clinical care, health finance, health reform, universal health care reform, project implementation, and working in all sectors: government, international organizations, non-profit and civil society, the private sector, and academia.